This compound is a deuterium-labeled derivative of a sulfonamide, characterized by a phenyl-substituted oxazole ring and a benzenesulfonamide group. It is primarily used as an active pharmaceutical ingredient in research and pharmaceutical manufacturing.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1219794-90-7
Trimetazidine-d8 Dihydrochloride
active pharmaceutical ingredient
Alpha3-(((1,1-Dimethylethyl)amino)methyl)-6-hydroxy-1,3-benzenedimethan-alpha1,alpha1,alpha3-d3-ol
Deuterated active pharmaceutical ingredient
Metoprolol-D7 Hydrochloride
beta-blocker active pharmaceutical ingredient
(+/-)-Ondansetron-d5 (methylimidazole-d5)
deuterated active pharmaceutical ingredient
Valdecoxib
non-steroidal anti-inflammatory drug
4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonyl chloride
Pharmaceutical intermediate for valdecoxib synthesis
5-Methyl-3,4-diphenyl-isoxazole
Pharmaceutical intermediate for parecoxib
Parecoxib
non-steroidal anti-inflammatory drug
4-[3-phenyl-5-(trideuteriomethyl)-1,2-oxazol-4-yl]benzenesulfonamide
LNPDTQAFDNKSHK-FIBGUPNXSA-N
[2H]C([2H])([2H])C1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N